Food Producers: European Chocolate: Pick 'n Mix

Core Conclusion

European chocolate equities are entering a historically divergent phase: the unprecedented drop in cocoa bean prices creates a clear cash-flow tailwind for suppliers (Barry Callebaut) and top-line headwinds for manufacturers (Lindt). The market has partially priced this divergence—BARN is up +6% re-rating YTD, LISN down -18%—but the MS cost model still points to -41% deflation in European pipeline costs by 2H26, implying further earnings dispersion ahead. We maintain Overweight on BARN and upgrade LISN to Equal-weight (from Underweight), as its risk-reward has become more balanced after a de-rating that broke the stock below 30x NTM P/E for the first time since 2013.

Theme 1: Cocoa Deflation Creates Divergent Paths for Suppliers vs. Manufacturers

The cocoa market flipped from multi-year inflation to a 30mt surplus in 2025/26, driving bean prices down 53% from their peak by early 2026. Although a ~30% rally since March softens the thesis, the MS Chocolate Cost Model still projects European manufacturer pipeline costs shifting from +13% inflation in 1Q26 to -21% deflation in 2Q26 and -41% in 2H26. For BARN (the supplier), this releases working capital: its estimated FY26E PBT/t is -34% below 2019 levels, but FCF increases 30% in 1H26 due to inventory unwinding. For LISN (the manufacturer), the same deflation forces price rollbacks. BARN’s global chocolate price turned negative in 1Q26 at -5.7% y/y (vs. +15.7% in 4Q25); Hershey’s North America price fell -4.0% y/y. LISN’s outsized cumulative pricing (+40% over four years) leaves it vulnerable—its US volume was -11.3% L52W, and its US share lost 49bps over 52 weeks. Price reinvestment will pressure LISN’s top-line growth before volume benefits materialise.

Theme 2: Market Pricing Has Shifted but Still Underestimates the Magnitude

YTD performance reflects the narrative: BARN stock -8% (EPS -14%) → +6% re-rating; LISN -17% (EPS 0%) → -18% de-rating. BARN’s re-rating suggests the market now sees its FCF story, but consensus estimates remain high: MS EPS is -2% below consensus for FY26E but +10% above for 2027-29E, implying the market still underestimates earnings normalization. LISN’s de-rating has compressed its valuation premium. Its NTM P/E broke below 30x for the first time since 2013, now ~29.5x 2026E (10yr avg ~35x). The LISN/BARN relative P/E spread is ~20% vs. a 10yr average of ~70%, and LISN’s premium to large-cap European Staples is ~25% vs. historical ~50%. This compression reduces downside risk but leaves limited upside given LISN’s mid-term OSG guidance was trimmed -40bps.

Theme 3: Evidence from Management and NielsenIQ Data

NielsenIQ data for the US multi-outlet channel shows LISN’s volume growth (ex-Easter) turned positive in early March but slipped again by May 2. LISN’s L12W volume is -10.8%, while its price growth remains high at +20.4% L12W (vs. total chocolate +9.8%). Private-label volume share is rising (+77bps L52W), and brands with lower pricing (M&M Mars, Hershey’s) show better volume resilience. Management commentary: BARN CFO expects cocoa at £2,000-3,000 short term; Mondelez CEO sees £2,500 as fair; Lindt CFO warns about low inventories and potential price spikes from El Niño. The key implication is that price rollbacks are likely to begin in 2H26, faster in Europe than the US due to higher retail pricing, private-label penetration, and retailer consolidation.

Key Risks

• Cocoa price reversal: The ~30% rally since March, combined with El Niño and US-Iran conflict, could sustain higher bean costs, delaying deflation and weakening BARN’s working capital release.
• Volume recovery lag: If price rollbacks are delayed or consumers remain cautious, BARN’s volume recovery (1Q26 volume -3.3% y/y; 3-year stack -7.5%) may disappoint.
• LISN’s pricing trap: LISN’s 27% L52W price increase in the US strains consumer affordability; share loss (-22bps L52W) could accelerate if private label or cheaper brands gain.
• Consensus estimates still high: MS is below consensus for BARN FY26E EPS (-2%) but above for 2027-29E (+10%); execution under new CEO Hein Schumacher (June 2 catalyst) is untested.
• FX and cost: Swiss franc strength and cocoa disease (swollen shoot) remain structural overhangs.

Valuation and Trading Implications

BARN’s 25x P/E for a 21% EPS CAGR and 6.0% FCF yield offers a compelling risk/reward, especially if cocoa deflation materializes as modeled. LISN’s upgrade to Equal-weight reflects the compressed premium, but its valuation limits upside—the 27x target P/E implies only ~8% upside from current ~29.5x. The key catalyst for BARN is the CEO update on June 2; for LISN, a sustained volume recovery in Nielsen data would soften the top-line concern. Investors should overweight BARN for the working-capital-driven FCF story and underweight LISN until volume trends inflect.